← Open Payments lookup

PHILLIP BOWMAN: Open Payments

NPI 1619231701 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,473 in 162 payments from 18 companies in 2025. Trend: 2023 $2,564 · 2024 $2,883 · 2025 $2,473

Food & beverage: $2,473
CompanyPaymentsAmount
ABBVIE INC.46$616
Ardelyx, Inc.15$249
Takeda Pharmaceuticals U.S.A., Inc.10$238
PFIZER INC.27$216
Janssen Biotech, Inc.15$216
Aimmune Therapeutics, Inc.12$188
Gilead Sciences, Inc.8$183
Madrigal Pharmaceuticals4$111
Regeneron Healthcare Solutions, Inc.5$95
GENZYME CORPORATION5$94

Products named: IBSRELA, RINVOQ, ENTYVIO, TREMFYA, DUPIXENT, ZENPEP, XELJANZ, SKYRIZI.

Industry payments across UT — which companies pay providers there.